Post Marketing Surveillance on Safety Evaluation of POMALYST® (Pomalidomide) Treatment of Multiple Myeloma in Korea
Clinical trial NCT03288974 · COMPLETED
Trial details
- NCT number
- NCT03288974
- Sponsor
- Celgene
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-12-28
- Primary completion
- 2023-11-16
- Enrollment
- 397
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.